Cargando…
Selective oestrogen receptor modulators lasofoxifene and bazedoxifene inhibit joint inflammation and osteoporosis in ovariectomised mice with collagen-induced arthritis
Objective. RA predominantly affects post-menopausal women and is strongly associated with development of generalised osteoporosis. To find treatments that target both joint manifestations and osteoporosis in RA is desirable. The third generation of selective oestrogen receptor modulators (SERMs) [la...
Autores principales: | Andersson, Annica, Bernardi, Angelina I., Stubelius, Alexandra, Nurkkala-Karlsson, Merja, Ohlsson, Claes, Carlsten, Hans, Islander, Ulrika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746431/ https://www.ncbi.nlm.nih.gov/pubmed/26424839 http://dx.doi.org/10.1093/rheumatology/kev355 |
Ejemplares similares
-
Effects of lasofoxifene and bazedoxifene on B cell development and function
por: Bernardi, Angelina I, et al.
Publicado: (2014) -
Trabecular bone loss in collagen antibody-induced arthritis
por: Grahnemo, Louise, et al.
Publicado: (2015) -
Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis
por: Islander, Ulrika, et al.
Publicado: (2011) -
Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss
por: Stubelius, Alexandra, et al.
Publicado: (2016) -
Estrogen regulates T helper 17 phenotype and localization in experimental autoimmune arthritis
por: Andersson, Annica, et al.
Publicado: (2015)